Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Living Alone in Old Age With Cognitive Impairment

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03330587
Recruitment Status : Recruiting
First Posted : November 6, 2017
Last Update Posted : September 25, 2019
Sponsor:
Information provided by (Responsible Party):
University of California, San Francisco

Brief Summary:

The purpose of this study is to better understand the experience of living alone in older age with cognitive impairment.

We recruit adults 55+ living alone with cognitive impairment such as Alzheimer's disease or mild cognitive impairment.

This study investigates the priorities and concerns of older adults living alone with cognitive impairment. Participants are interviewed 5 times for one hour in their homes within 3 months at a time that works for them.


Condition or disease
Living Alone Alzheimer Disease Mild Cognitive Impairment

Detailed Description:

The purpose of this study is to better understand the experience of living alone in older age with cognitive impairment. This knowledge is important to design programs that are appropriate. Dr. Elena Portacolone, an Assistant Professor from the Institute of Health and Aging is the study researcher.

Study participants are interviewed by Elena at a time and place convenient to them, usually their home. Interviews are audio recorded and last around one hour. Study participants are interviewed five times within 3 months.

After the interview, a transcriptionist will type into a computer the recording and will remove personal names. The sound recording will then be destroyed.

Participants can stop being in the study at any time.

Layout table for study information
Study Type : Observational
Estimated Enrollment : 60 participants
Observational Model: Ecologic or Community
Time Perspective: Prospective
Official Title: Living Alone in Old Age With Cognitive Impairment
Actual Study Start Date : March 1, 2016
Estimated Primary Completion Date : May 20, 2020
Estimated Study Completion Date : September 1, 2020

Resource links provided by the National Library of Medicine





Primary Outcome Measures :
  1. Ethnographic interviews [ Time Frame: One hour ]
    Questions that follow the train of thought of study participants



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   55 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Persons over 55 years of age living alone and having a medical diagnosis of Alzheimer's disease or mild cognitive impairment
Criteria

Inclusion Criteria:

  • Living alone
  • Medical diagnosis of Alzheimer's disease or mild cognitive impairment

Exclusion Criteria:

  • Living in nursing homes, assistive living facilities.
  • Alcohol abuse

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03330587


Contacts
Layout table for location contacts
Contact: Elena Portacolone, PhD MPH MBA 5108309309 elena.portacolone@ucsf.edu
Contact: Sahru Keiser, MPH 4153425395 sahru.keiser@ucsf.edu

Locations
Layout table for location information
United States, California
Institute for Health & Aging Recruiting
San Francisco, California, United States, 94705
Contact: Elena Portacolone, PhD MBA MPH    510-830-9309    elena.portacolone@ucsf.edu   
Sponsors and Collaborators
University of California, San Francisco
Investigators
Layout table for investigator information
Principal Investigator: Elena Portacolone, PhD MPH MBA University of California, San Francisco
Additional Information:
Layout table for additonal information
Responsible Party: University of California, San Francisco
ClinicalTrials.gov Identifier: NCT03330587    
Other Study ID Numbers: K01AG049102 ( U.S. NIH Grant/Contract )
First Posted: November 6, 2017    Key Record Dates
Last Update Posted: September 25, 2019
Last Verified: September 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Alzheimer Disease
Cognitive Dysfunction
Dementia
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Tauopathies
Neurodegenerative Diseases
Neurocognitive Disorders
Mental Disorders
Cognition Disorders